Read + Share
Ge Y, Zhan Y, He J, Li J, et al. PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in
PD-L1-negative metastatic lung adenocarcinoma: a real-world data. J Cancer Res Clin Oncol 2024;150:135.
PMID: 38499838
|
 |
|
Ge Y, Zhan Y, He J, Li J, et al. PD-(L)1 inhibitors plus bevacizumab and chemotherapy as first-line therapy in
PD-L1-negative metastatic lung adenocarcinoma: a real-world data. J Cancer Res Clin Oncol 2024;150:135.
PMID: 38499838
|
|
|
|